These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10404879)
61. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
62. Ante mortem diagnosis of tuberculosis in cattle: a review of the tuberculin tests, gamma-interferon assay and other ancillary diagnostic techniques. de la Rua-Domenech R; Goodchild AT; Vordermeier HM; Hewinson RG; Christiansen KH; Clifton-Hadley RS Res Vet Sci; 2006 Oct; 81(2):190-210. PubMed ID: 16513150 [TBL] [Abstract][Full Text] [Related]
63. Experimental risk assessment of bovine viral diarrhea virus transmission via in vitro embryo production using somatic cell nucleus transfer. Gregg K; Chen SH; Sadeghieh S; Guerra T; Xiang T; Meredith J; Polejaeva I Theriogenology; 2009 Jul; 72(1):99-110. PubMed ID: 19349070 [TBL] [Abstract][Full Text] [Related]
64. [Comparison of performance of dairy herds that were or were not vaccinated with a bovine herpes virus 1 marker vaccine in 1998]. Bartels CJ; Barkema HW; Beiboer ML; Bouma A; Stegeman JA Tijdschr Diergeneeskd; 2001 Mar; 126(6):191-7. PubMed ID: 11285639 [TBL] [Abstract][Full Text] [Related]
65. Effect of bacterial toxins in serum on the chromosomes of WI-38. Whitaker AM; Smith EM Dev Biol Stand; 1976 Dec 13-15; 37():185-90. PubMed ID: 801471 [TBL] [Abstract][Full Text] [Related]
66. Testing Serum Batches for Mouse Embryonic Stem Cell Culture. Behringer R; Gertsenstein M; Nagy KV; Nagy A Cold Spring Harb Protoc; 2017 Dec; 2017(12):pdb.prot092411. PubMed ID: 29196597 [TBL] [Abstract][Full Text] [Related]
68. Relationship between nature and source of risk and process validation. Berthold W; Werz W; Walter JK Dev Biol Stand; 1996; 88():59-71. PubMed ID: 9119164 [No Abstract] [Full Text] [Related]
69. Quality of biotechnological products: derivation and characterisation of cell substrates used for production of biotechnological/biological products. ICH Harmonised Tripartite Guideline. Dev Biol Stand; 1998; 93():223-34. PubMed ID: 9737399 [No Abstract] [Full Text] [Related]
70. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50). Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395 [No Abstract] [Full Text] [Related]
71. Adventitious viral agents in biological products. Minor P Dev Biol Stand; 1989; 70():173-9. PubMed ID: 2547677 [TBL] [Abstract][Full Text] [Related]
73. Meeting on the acceptance criteria for virus validation studies. Langen 10 November, 1994. Minor PD Biologicals; 1995 Mar; 23(1):107-10. PubMed ID: 7619427 [No Abstract] [Full Text] [Related]
74. Control of product batches (before and after registration). The British approach. Lee AM Dev Biol Stand; 1992; 79():175-7. PubMed ID: 1286754 [TBL] [Abstract][Full Text] [Related]
75. [Batch documentation of blood products]. Bornmann L Infusionsther Transfusionsmed; 1995 Aug; 22(4):258-63. PubMed ID: 7496126 [TBL] [Abstract][Full Text] [Related]
76. [Properties of blood serum from reindeer and results of using it in virology and biotechnology]. Gunenkov VV; Sukharev OI; Sirota VF Vopr Virusol; 2003; 48(6):37-41. PubMed ID: 14708230 [TBL] [Abstract][Full Text] [Related]